Inside Access, Outside the Rules - Report - MDSpire

Inside Access, Outside the Rules

Two federal cases highlight alleged misuse of professional roles in health care settings

  • By

  • Kerri Miller

  • April 1, 2026

  • 3 min

Share

Clinical Report: Diversion Risks in Pharmacy and Telemedicine Fraud

Overview

Revise to emphasize the broader implications of these cases for the healthcare system.

Background

The diversion of controlled substances poses a critical risk to patient safety and healthcare integrity. Recent cases illustrate the vulnerabilities within pharmacy operations and telemedicine practices, emphasizing the need for robust oversight and preventive measures. Understanding these risks is essential for healthcare professionals to safeguard against potential abuses in their practices.

Data Highlights

No numerical data available in the source material.

Key Findings

  • A Kansas pharmacist was indicted for allegedly diverting controlled substances from his employer.
  • The pharmacist is accused of illegally obtaining medications such as Adderall and oxycodone without authorization.
  • A telemedicine company owner pleaded guilty to orchestrating a Medicare fraud scheme involving over $46 million in claims.
  • The fraud scheme included aggressive telemarketing and billing for unnecessary medical equipment.
  • The Justice Department has charged over 6,200 defendants in healthcare fraud cases since 2007, reflecting a significant issue within the healthcare system.

Clinical Implications

Healthcare professionals must implement stringent diversion prevention programs to mitigate risks associated with controlled substances. Additionally, awareness of fraudulent practices in telemedicine is crucial for maintaining ethical standards and protecting patient welfare.

Conclusion

Reiterate the importance of ongoing education and provide examples of guidelines.

References

  1. U.S. Department of Justice, Office of Public Affairs, 2026 -- Telemedicine Fraud Scheme
  2. American Society of Health-System Pharmacists, 2022 -- Guidelines on Preventing Diversion of Controlled Substances
  3. Optometric Management — End-Of-The-Year Article Index
  4. Ophthalmology Management — Creating ASC Efficiencies Outside the OR
  5. Optometric Management — LEADING OFF: CEO Challenge
  6. Eyecare Business — Theft & The Aftermath: An Inside Job
  7. End-Of-The-Year Article Index
  8. Creating ASC Efficiencies Outside the OR
  9. LEADING OFF: CEO Challenge
  10. ASHP Guidelines on Preventing Diversion of Controlled Substances | American Journal of Health-System Pharmacy | Oxford Academic
  11. Prescription Default Nudges for Opioid Reduction after Major Surgery (NORMS): A Randomized Controlled Trial - PubMed
  12. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

Original Source(s)

Inside Access, Outside the Rules

  • by Kerri Miller

  • April 1, 2026

Related Content

Rapid AST Speeds Care, Not Outcomes

Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.

Shorter TB Regimens Advance Care

Review highlights shorter tuberculosis regimens while warning that rising bedaquiline resistance may threaten future progress.

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.